Bridgeway Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-34,200	Closed	-$505K	–	1380
2024 Q1	$505K	Hold	34,200	–	–	0.01%	922
2023 Q4	$459K	Hold	34,200	–	–	0.01%	960
2023 Q3	$422K	Hold	34,200	–	–	0.01%	927
2023 Q2	$421K	Hold	34,200	–	–	0.01%	956
2023 Q1	$420K	Hold	34,200	–	–	0.01%	923
2022 Q4	$392K	Hold	34,200	–	–	0.01%	944
2022 Q3	$128K	Sell	34,200 -25,000	-42%	-$93.6K	﹤0.01%	1228
2022 Q2	$352K	Hold	59,200	–	–	0.01%	961
2022 Q1	$374K	Hold	59,200	–	–	0.01%	1015
2021 Q4	$231K	Hold	59,200	–	–	﹤0.01%	1139
2021 Q3	$286K	Hold	59,200	–	–	0.01%	1164
2021 Q2	$378K	Sell	59,200 -5,000	-8%	-$31.9K	0.01%	1149
2021 Q1	$403K	Buy	64,200 +2,500	+4%	+$15.7K	0.01%	1155
2020 Q4	$425K	Hold	61,700	–	–	0.01%	1008
2020 Q3	$247K	Hold	61,700	–	–	0.01%	1131
2020 Q2	$205K	Hold	61,700	–	–	﹤0.01%	1147
2020 Q1	$133K	Hold	61,700	–	–	﹤0.01%	1140
2019 Q4	$194K	Hold	61,700	–	–	﹤0.01%	1200
2019 Q3	$277K	Sell	61,700 -16,721	-21%	-$75.1K	﹤0.01%	1113
2019 Q2	$373K	Buy	78,421 +44,485	+131%	+$212K	﹤0.01%	1050
2019 Q1	$186K	Buy	+33,936	New	+$186K	﹤0.01%	1232
2018 Q4	–	Sell	-80,327	Closed	-$337K	–	1537
2018 Q3	$337K	Hold	80,327	–	–	﹤0.01%	1228
2018 Q2	$310K	Buy	+80,327	New	+$310K	﹤0.01%	1242